SPAC Overview
Timeline Progress
About
Paramount Acquisition Corp is a newly organized blank-check company seeking to acquire an operating business in the healthcare industry through a merger, stock exchange, asset acquisition or similar business combination. It has not identified a target business and was formed to pursue a business combination.
Investment Focus
Healthcare
The terms and the filing trail behind Paramount Acquisition Corp
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Extended Team Information
The management team includes investment banking, asset-management, healthcare and biomedical professionals. Lindsay A. Rosenwald has led Paramount BioCapital organizations and invested in biomedical and life-science companies; J. Jay Lobell has legal and operating experience; I. Keith Maher has asset-management and equity research experience; Michael Weiser has biomedical research and pharmaceutical company experience. Directors Arie Belldegrun and Isaac Kier bring biotechnology, healthcare, venture-capital and corporate experience.